LncRNA-H19 regulates chemoresistance to carboplatin in epithelial ovarian cancer through microRNA-29b-3p and STAT3

Background: Platinum-based chemotherapy is part of current standard treatment for epithelial ovarian cancer (EOC). However, chemoresistance often rapidly developed, leading to chemotherapy failure and unfavored prognosis. Increasing evidence has demonstrated the important role of oncogenic long nonc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Xueye, Zuo, Xiaohang, Hou, Meng, Li, Chen, Teng, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408112/
https://www.ncbi.nlm.nih.gov/pubmed/34475985
http://dx.doi.org/10.7150/jca.58979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408112/
https://www.ncbi.nlm.nih.gov/pubmed/34475985
http://dx.doi.org/10.7150/jca.58979

Ejemplares similares